MUC16 and ovarian carcinoma: Indeed, MUC16 (cancer antigen 125, CA 125) is used in clinics to diagnose and predict prognosis in ovarian cancer patients, but it is also upregulated in a large percentage of digestive tract adenocarcinomas and has been proposed as a prognostic marker for gastrointestinal cancers [63].